← Back to results
Federal

Protecting Health Care for All Patients Act of 2023

Source: Congress.gov  ·  1,197 words in original text
This bill stops federal health care programs from using quality-adjusted life years (a way of measuring how much a treatment extends someone's life based on its quality) when deciding what treatments to cover or how much to pay for them. The bill also prevents these programs from treating treatments that extend the lives of elderly, disabled, or terminally ill people as less valuable than treatments for younger or healthier people.
Federal agencies running health care programs; States running Medicaid (health insurance for low-income people) and CHIP (Children's Health Insurance Program); Medicare Advantage plans (an alternative to traditional Medicare); prescription drug plans under Medicare; managed care organizations (companies that deliver health insurance services); and people enrolled in these health care programs.
• Federal agencies and States cannot use quality-adjusted life years or similar measures in decisions about what treatments to cover or how much to pay for treatments (Sec. 2(a)). • Federal agencies and States cannot treat extending the life of an elderly, disabled, or terminally ill person as less valuable than extending the life of a younger or healthier person (Sec. 2(a)). • States must make sure their Medicaid programs follow the rules about not using quality-adjusted life years (Sec. 2(b)(1)). • Medicare Advantage plans must follow the same rules as the federal government about not using quality-adjusted life years (Sec. 2(b)(3)). • Prescription drug plans under Medicare must follow the same rules about not using quality-adjusted life years (Sec. 2(b)(4)).
Federal health care programs and States lose the ability to use quality-adjusted life years as a tool for making coverage and payment decisions. Agencies also cannot get around these rules by requesting special waivers or demonstrations (test programs) to use these measures.
Quality-adjusted life year: A way of measuring a treatment's value based on how long it extends someone's life and the quality of that extra life. Not specified in bill text for other key terms.
Not specified in bill text
Important: This plain English summary was generated by AI and is provided for informational purposes only. It is not legal advice. Always consult the official bill text on Congress.gov or a qualified attorney for legal matters.